Skip to main content
. Author manuscript; available in PMC: 2017 May 15.
Published in final edited form as: J Immunol. 2016 Apr 13;196(10):4311–4321. doi: 10.4049/jimmunol.1501443

Figure 2.

Figure 2

NCM460-NTR1 cells were pretreated as indicated with (A) the HIF-1α inhibitor PX-478 (40 × 10−6 M, 18 h) and/or NT (10−7 M, 6 h) or (B) transfected with si-HIF-1α or siRNA-A control and/or NT (10−7 M, 6 h) 48 h following transfection. MiR-210 levels of expression were assessed using qPCR (n=6, figure panels representative of three separate experiments). Statistical analysis was performed using student’s t test. *p<0.05, **p<0.01, ***p<0.001